Investigation of the Effect of Food on the Bioavailability of a 25 mg Empagliflozin Tablet as Well as Assessment of Dose Proportionality Between 10 mg and 25 mg Empagliflozin Tablets Under Fasting Conditions.

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

November 30, 2011

Conditions

Healthy

Interventions

DRUG

Empagliflozin

high dose of empagliflozin after overnight fasting for at least 10 h

DRUG

Empagliflozin

low dose empagliflozin after overnight fasting for at least 10 h

DRUG

Empagliflozin

high dose of empagliflozin after a standardised high fat breakfast

Trial Locations (1)

1245.79.1 Boehringer Ingelheim Investigational Site, Biberach